meddevicedb.com FDA Device Reference

MILES ASPARTATE AMINOTRANSFERASE SERA-PAK METHOD

K920336 Class II Traditional
Decision Date
1992-03-04
Sponsor / Applicant
Heraeus Kulzer, Inc.

Technical Specification

510(k) Submission ID K920336
Product Code CIT
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1100
Decision Date 1992-03-04
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

MILES ASPARTATE AMINOTRANSFERASE SERA-PAK METHOD received FDA 510(k) clearance under submission number K920336, sponsored by Heraeus Kulzer, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1992-03-04.

Classification & Regulation

This clearance is catalogued under FDA product code CIT and 21 CFR 862.1100, within the Clinical Chemistry review panel as a Class II device.